We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+0.38%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.1B
AUM Growth
-$502M
(-4%)
Cap. Flow
-$489M
Cap. Flow
% of AUM
-4.05%
Top 10 Holdings %
Top 10 Hldgs %
13.99%
Holding
580
New
160
Increased
90
Reduced
147
Closed
142
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Check Point Software Technologies
CHKP
|
+$181M |
| 2 |
Philip Morris
PM
|
+$152M |
| 3 |
Broadcom
AVGO
|
+$140M |
| 4 |
Bank of America
BAC
|
+$111M |
| 5 |
Dominion Energy
D
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AutoZone
AZO
|
+$193M |
| 2 |
GE Aerospace
GE
|
+$149M |
| 3 |
Acuity Brands
AYI
|
+$143M |
| 4 |
KeyCorp
KEY
|
+$133M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.78% |
| 2 | Industrials | 13.32% |
| 3 | Healthcare | 10.76% |
| 4 | Energy | 9.69% |
| 5 | Consumer Discretionary | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DERM
401
DELISTED
Dermira, Inc.
DERM
| $800K | 0.01% |
100,156
-100,903
| -50% | -$2.2M |
|
402
Boot Barn
BOOT
$4.95B
| $798K | 0.01% |
+44,995
| New | +$811K |
|
403
Installed Building Products
IBP
$6.49B
| $795K | 0.01% |
+13,243
| New | +$880K |
|
|
ALDR
404
DELISTED
Alder Biopharmaceuticals
ALDR
| $773K | 0.01% |
60,865
-549
| -0.9% | -$7.94K |
|
|
DSKE
405
DELISTED
Daseke, Inc. Common Stock
DSKE
| $769K | 0.01% |
78,579
-421,421
| -84% | -$5.03M |
|
|
CTIC
406
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $767K | 0.01% |
+196,752
| New | +$692K |
|
407
Visa
V
$677B
| $695K | 0.01% |
5,807
-7,278
| -56% | -$882K |
|
|
AGRX
408
DELISTED
Agile Therapeutics
AGRX
| $666K | 0.01% |
130
-28
| -18% | -$185K |
|
409
Inovio Pharmaceuticals
INO
$69M
| $657K | 0.01% |
11,622
-105
| -0.9% | -$5.68K |
|
410
Micron Technology
MU
$991B
| $647K | 0.01% |
12,413
-698,518
| -98% | -$33.4M |
|
411
Summit Therapeutics
SMMT
$11.1B
| $639K | 0.01% |
49,553
-447
| -0.9% | -$5.58K |
|
|
LJPC
412
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $628K | 0.01% |
+21,075
| New | +$680K |
|
413
Sol-Gel Technologies
SLGL
$288M
| $612K | 0.01% |
+5,946
| New | +$666K |
|
|
ADVM
414
DELISTED
Adverum Biotechnologies
ADVM
| $528K | ﹤0.01% |
+9,100
| New | +$567K |
|
|
EGLT
415
DELISTED
Egalet Corporation
EGLT
| $526K | ﹤0.01% |
834,880
-7,522
| -0.9% | -$6.51K |
|
416
Minerva Neurosciences
NERV
$199M
| $507K | ﹤0.01% |
10,148
-91
| -0.9% | -$4.37K |
|
|
IPHI
417
DELISTED
INPHI CORPORATION
IPHI
| $479K | ﹤0.01% |
+15,905
| New | +$494K |
|
|
CDTX
418
DELISTED
Cidara Therapeutics
CDTX
| $387K | ﹤0.01% |
4,840
-44
| -0.9% | -$6.01K |
|
|
SAGE
419
DELISTED
Sage Therapeutics
SAGE
| $383K | ﹤0.01% |
2,375
-153,254
| -98% | -$26M |
|
|
KA
420
DELISTED
Kineta, Inc. Common Stock
KA
| $380K | ﹤0.01% |
571
-143
| -20% | -$86.3K |
|
421
Cactus
WHD
$5.44B
| $347K | ﹤0.01% |
+12,900
| New | +$325K |
|
|
LEAF
422
DELISTED
Leaf Group Ltd.
LEAF
| $337K | ﹤0.01% |
+47,856
| New | +$390K |
|
|
FSNN
423
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
| $316K | ﹤0.01% |
+65,294
| New | +$316K |
|
424
Zai Lab
ZLAB
$2.62B
| $298K | ﹤0.01% |
13,974
-102,181
| -88% | -$2.32M |
|
425
First American
FAF
$7.58B
| $282K | ﹤0.01% |
+4,804
| New | +$282K |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q1 2018 Portfolio in Review
As of Q1 2018, Alyeska Investment Group held 580 positions worth $12.1B, down 4% from $12.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Alyeska Investment Group withdrew a net $489M in Q1 2018, closing 142 positions and reducing 147 holdings. Its most notable exit was GE Aerospace, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Alyeska Investment Group opened a new position in Philip Morris worth $145M.
- Alyeska Investment Group's largest Q1 2018 buy was Philip Morris: 1,458,712 shares worth $145M.
- Alyeska Investment Group added most to Check Point Software Technologies in Q1 2018, an estimated $181M increase.
- Alyeska Investment Group's biggest Q1 2018 reduction was AutoZone, cutting an estimated $193M.
- Alyeska Investment Group fully exited GE Aerospace in Q1 2018, selling an estimated $149M.
- Alyeska Investment Group's ten largest holdings make up 14% of its $12.1B portfolio in Q1 2018.
- Alyeska Investment Group opened 160 new positions and closed 142 in Q1 2018.
- Alyeska Investment Group's portfolio value fell 4% quarter-over-quarter to $12.1B.
Based on Alyeska Investment Group's 13F filing for Q1 2018, filed 15 May 2018.